Ironwood Pharmaceuticals Inc (IRWD)-Financial and Strategic SWOT Analysis Review

Ironwood Pharmaceuticals Inc (IRWD)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH130084FSA
  • |
  • Pages: 57
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Ironwood Pharmaceuticals Inc (IRWD)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ironwood Pharmaceuticals Inc (Ironwood) is a commercial biotechnology company that discovers, develops and commercializes medicines for gastrointestinal disorders. The company's major products include Linzess (linaclotide), an oral capsule for the treatment of irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) in adults; Zurampic (lesinurad) and Duzallo (lesinurad and allopurinol), for the treatment of hyperuricemia associated with gout. Ironwood also evaluates linaclotide in other indications, new formulations and in combination with other products in various GI conditions including IBS-C or CIC in pediatrics, abdominal pain associated with IBS and uncontrolled gastroesophageal reflux disease. Its other product candidates are intended for the treatment of diabetic nephropathy and heart failure with preserved ejection fraction; and specialty diseases, including sickle cell disease and achalasia. Ironwood is headquartered in Cambridge, Massachusetts, the US.

Ironwood Pharmaceuticals Inc Key Recent Developments

Feb 15,2018: Ironwood Pharmaceuticals Reports Fourth Quarter 2017 Financial Results

Nov 28,2017: Ironwood Pharmaceuticals Strengthens Executive Leadership Team

Nov 02,2017: Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update

Sep 06,2017: Ironwood Pharmaceuticals Announces Leadership Change

Aug 03,2017: Ironwood Pharmaceuticals Provides Second Quarter 2017 Investor Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Ironwood Pharmaceuticals Inc-Key Facts

Ironwood Pharmaceuticals Inc-Key Employees

Ironwood Pharmaceuticals Inc-Key Employee Biographies

Ironwood Pharmaceuticals Inc-Major Products and Services

Ironwood Pharmaceuticals Inc-History

Ironwood Pharmaceuticals Inc-Company Statement

Ironwood Pharmaceuticals Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Ironwood Pharmaceuticals Inc-Business Description

Ironwood Pharmaceuticals Inc-Corporate Strategy

Ironwood Pharmaceuticals Inc-SWOT Analysis

SWOT Analysis-Overview

Ironwood Pharmaceuticals Inc-Strengths

Ironwood Pharmaceuticals Inc-Weaknesses

Ironwood Pharmaceuticals Inc-Opportunities

Ironwood Pharmaceuticals Inc-Threats

Ironwood Pharmaceuticals Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018

Ironwood Pharmaceuticals Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Nov 28, 2017: Ironwood Pharmaceuticals Strengthens Executive Leadership Team

Nov 02, 2017: Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update

Sep 06, 2017: Ironwood Pharmaceuticals Announces Leadership Change

Aug 03, 2017: Ironwood Pharmaceuticals Provides Second Quarter 2017 Investor Update

May 08, 2017: Ironwood Pharmaceuticals Provides First Quarter 2017 Investor Update

Apr 06, 2017: Ironwood Pharmaceuticals Appoints Dr. Christopher Wright as Senior Vice President of Global Development and Chief Development Officer

Feb 21, 2017: Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update

Jan 08, 2017: Ironwood Pharmaceuticals Demonstrates Strong Execution on Strategy to Build Top-Performing Commercial Biotech

Jan 04, 2017: Ironwood Pharmaceuticals Appoints Amy Schulman to Board of Directors

Jan 04, 2017: Ironwood Pharmaceuticals Appoints Amy Schulman to Board of Directors

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Figures

Ironwood Pharmaceuticals Inc, Performance Chart (2013-2017)

Ironwood Pharmaceuticals Inc, Ratio Charts

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

List of Tables

Ironwood Pharmaceuticals Inc, Key Facts

Ironwood Pharmaceuticals Inc, Key Employees

Ironwood Pharmaceuticals Inc, Key Employee Biographies

Ironwood Pharmaceuticals Inc, Major Products and Services

Ironwood Pharmaceuticals Inc, History

Ironwood Pharmaceuticals Inc, Subsidiaries

Ironwood Pharmaceuticals Inc, Key Competitors

Ironwood Pharmaceuticals Inc, Ratios based on current share price

Ironwood Pharmaceuticals Inc, Annual Ratios

Ironwood Pharmaceuticals Inc, Annual Ratios (Cont...1)

Ironwood Pharmaceuticals Inc, Interim Ratios

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018

Ironwood Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 125 INR 8905
Site License
USD 250 INR 17810
Corporate User License
USD 375 INR 26715

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com